Navigation Links
Study uncovers how Ritalin works in brain to boost cognition, focus attention
Date:6/24/2008

indicate these meds have lately been embraced by healthy Americans of all ages as a means to boost mental performance.

Yet, despite their prevalence, we know remarkably little about how these drugs work, especially at lower doses that have been proven clinically to calm behavior and focus attention in ADHD patients, says Berridge. In 2006, his team reported that therapeutic doses of Ritalin boosted neurotransmitter levels primarily in the PFC, suggesting a selective targeting of this region of the brain. Since then, he and Devilbiss have focused on how Ritalin acts on PFC neurons to enhance cognition.

To answer this, the pair studied PFC neurons in rats under a variety of Ritalin doses, including one that improved the animals' performance in a working memory task of the type that ADHD patients have trouble completing. Using a sophisticated new system for monitoring many neurons at once through a set of microelectrodes, the scientists observed both the random, spontaneous firings of PFC neurons and their response to stimulation of an important pathway into the PFC, the hippocampus.

Much like tiny microphones, the electrodes record a pop every time a neuron fires, Devilbiss explains. Analyzing the complex patterns of "voices" that emerge is challenging but also powerful, because it allows study of neurons on many levels.

"Similar to listening to a choir, you can understand the music by listening to individual voices," says Devilbiss, "or you can listen to the interplay between the voices of the ensemble and how the different voices combine."

When they listened to individual PFC neurons, the scientists found that while cognition-enhancing doses of Ritalin had little effect on spontaneous activity, the neurons' sensitivity to signals coming from the hippocampus increased dramatically. Under higher, stimulatory doses, on the other hand, PFC neurons stopped responding to incoming information.

"This suggests that the
'/>"/>

Contact: David Devilbiss
ddevilbiss@wisc.edu
608-265-8722
University of Wisconsin-Madison
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Cosmetic surgery procedures to exceed 55 million in 2015, ASPS study predicts
2. HealthGrades releases Fifth Annual Womens Health in American Hospitals study
3. Study further defines potential role of fish-based fatty acids in resolving, preventing asthma
4. Study evaluates factors associated with racial disparities in colon cancer screening
5. Study in Circulation provides detail on how low blood flow promotes vascular disease
6. Study shows that chronic grief activates pleasure areas of the brain
7. Researchers seek children for a study of antibiotics for a urinary tract disorder
8. NIH funds highway pollution and health study in Boston, Somerville
9. Study links vitamin D to colon cancer survival
10. Study: Medicare Competitive Bidding Program Could Impede Seniors Access to Diabetes Testing Supplies
11. Study finds Childrens Hospital patient safety program improves caregiver/family communications

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...tudy finds , , MONDAY, Nov. 9 (HealthDay...atrial enlargement, which increases the risk of at...hows. , Atrial fibrillation is the most common ...eartbeat). , Researchers analyzed data on 1,21...e followed for 10 years. The study authors conclud...
(Date:11/9/2009)...everybody,s buzz word today and for Recruiters and... Recruiters and Staffers create their own private ... and close positions. The site also enables indivi...k with recruiters. , (PRW...everyone to network more than ever and by the laun...
(Date:11/9/2009)... mood despite similar weight loss , , MO...low-carbohydrate diet such as the popular Atkins p...p people lose pounds over the course of a year. ,...esult in long-term improvement in mood, according ...ernal Medicine . , People on both diets consume...
(Date:11/9/2009)...e-FirstCall/ - Hard To Treat Diseases (HTDS.PK) w..., a US$41 billion international healthcare company...partner, Zhejiang Tianyuan Bio-Pharmaceutical Co.,... will begin a five-year, $1 billion China initiati...crease its investment in its China R&D facilit...
(Date:11/9/2009)...Offered in April 2010, Provides First Responders w...Cambridge, MA (Vocus) November 9, 2009 -- When Ste...irst inspected a suspected mass grave at Dasht-e-... team of experts to help interpret the scene. He k...irst step in securing evidence of a human rights v...
Breaking Medicine News(10 mins):Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4
...Austin and,Amadeus North America, Inc. will receiv...nd for a corporation in recognition of their contr...s will be presented on Friday,February 15 at the S...rn Cruise Line, one of the most influential and in...
...s was able to identify the location and defect in ...genetic material (DNA) from members of a large Swi...somal dominant juvenile cataract. The correspondin... also lead to the condition of renal glucosuria, a...
...ience University Cancer Institute researcher has f... to predict if a mans prostate cancer is going to ...make this discovery, researchers examined prostate...cing of the gene CDH13 had a five-fold increased r...
...ic,Corporation (NYSE: BSX ) today announced that ...and Venous Access businesses to Avista Capital,Par...he definitive,agreement announced on December 13, ...ion., "The sale of the Fluid Management and Venou...
...ontinuing its commitment to honor invention and in...recognized the next group of world-class inventors...influential class includes inventors such as Nick ...l that converted solar energy into electrical powe...
... Minnesotans, MINNEAPOLIS, Feb. 14 Many smokers ... birthday or holiday as a "quit date.",Valentine,s...perfect day to,quit smoking for that special someo...uitting, such as not smelling like smoke,are obvio...
Other Medicine News:Health News:Executive Alison Austin and Amadeus North America Receive Deborah Natansohn Awards for Support of Heart Disease Awareness in Women 2Health News:New cataract gene discovered 2Health News:OHSU cancer institute researcher discovers new predictor of prostate cancer recurrence 2Health News:Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners 2Health News:Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners 3Health News:Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners 4Health News:National Inventors Hall of Fame announces 2008 inductees 2Health News:National Inventors Hall of Fame announces 2008 inductees 3Health News:National Inventors Hall of Fame announces 2008 inductees 4Health News:QUITPLAN(R) Services Can Help Make Valentine's Day Smoke-Free 2Health News:QUITPLAN(R) Services Can Help Make Valentine's Day Smoke-Free 3
(Date:11/9/2009)... AMD LASERS just announced that in...e, has accepted the position of Medical Director. ...r overseeing research and development of new soft ...iance for continuing education credits, authoring ...ations, and lecturing and seminar engagements. ,...
(Date:11/9/2009).... 9 Access MediQuip, LLC, the nati...antable medical device management solutions to the...elocating its corporate headquarters to Lake Mary,...ued rapid growth, includes a major expansion of th...pen in January 2010 and relocation and expansion o...
(Date:11/9/2009)...v. 9 Thomson Reuters today annou...Focus, a leading clinical surveillance solution th...in real-time and respond immediately to improve cl... ,, This upgrade is available to current CareFo...ocus 2.0 contains several powerful enhancements th...
Breaking Medicine Technology:AMD LASERS Names Dr. James Jesse as Medical Director 2Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3HealthCare Partners IPA Dr Richard Merkin CEO Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington DC 5314 1HealthCare Partners IPA Dr Richard Merkin CEO Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington DC 5314 2HealthCare Partners IPA Dr Richard Merkin CEO Recognize Seniors Taking Their Healthcare Concerns Directly to Lawmakers in Washington DC 5314 3Argonne 26apos 3Bs Advanced Photon Source Lit the Way to Chemistry Nobel 14392 1Argonne 26apos 3Bs Advanced Photon Source Lit the Way to Chemistry Nobel 14392 2Argonne 26apos 3Bs Advanced Photon Source Lit the Way to Chemistry Nobel 14392 3Statement from Senators Daschle and Dole 59109 1
...NAPOLIS, Feb. 26 America,s pharmaceutical researc... number of potential medicines to treat two of the...port by the Pharmaceutical Research and Manufactur...h pipeline, over 300 new medicines are in developm... report reflects the never-ending commitment of ou...
...ubset analysis of bortezomib-relapsed patient popu...extended time to progression , , NEW YORK, Feb. 2...) today announced updated clinical results from an...in combination with bortezomib (+/- dexamethasone)...loma. The data, which was presented earlier today ...
Other Medicine Technology:Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis 2Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis 3Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting 4
Myoglobin ELISA
...for the quantitative determination of prolactin in...s and treatment of disorders of the anterior pitui...titative Test is based on the principle of a solid...y system utilized sheep anti-prolactin for solid p...
Prolactin EIA kit
... kit for the quantitative determination of Human P...noassay (EIA) permits the routine quantitative det... and provides an accurate, sensitive, reproducible...y method makes it possible to measure low concentr...
Medicine Products: